Denise O’Leary
About Denise O’Leary
Denise M. O’Leary, age 67, is an independent director of American Airlines Group Inc. (AAL) since 2013. She is a private venture capital investor and former General Partner at Menlo Ventures, with a BS in Industrial Engineering from Stanford University and an MBA from Harvard University. She currently serves as Chair of the Compensation Committee (pre–2025 annual meeting) and as a member of the Finance Committee; after the 2025 annual meeting she is expected to join the Corporate Governance & Public Responsibility Committee (CGPR) as membership rotates. Her credentials emphasize four decades in investment and financial leadership and extensive public company board experience.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Menlo Ventures | Partner | 1987–1996 | VC investing and portfolio oversight |
| Medtronic plc | Director | 2000–2024 | Long-tenure medical devices board service |
| Calpine Corporation | Director | 2009–2018 | Power generation governance |
| US Airways Group, Inc. | Director | 2005–2013 | Airline governance pre-merger with AAL |
| Chiron Corporation | Director | 2002–2006 | Biotech governance; acquired by Novartis |
| America West Holdings Corp. | Director | 1998–2005 | Airline governance; merged into US Airways |
| Del Monte Foods, Inc. | Director | 1997–2002 | Consumer foods governance |
| Alza Corporation | Director | 1996–2001 | Pharma governance; acquired by J&J |
External Roles
| Organization | Role | Tenure/Status |
|---|---|---|
| University of Denver | Chair Emerita, Board of Trustees | Ongoing affiliation |
| Smithsonian Institution | Citizen Regent, Board of Regents | Ongoing affiliation |
Board Governance
- Committee assignments (2024–2025 proxy slate): Compensation Committee Chair; Finance Committee Member. Expected post–June 11, 2025: Doug Steenland to become Compensation Chair; Vicente Reynal to chair Finance and replace O’Leary on Finance; O’Leary to join CGPR.
- Independence: Board determined all directors and the new nominee are independent under AAL’s Governance Guidelines and Nasdaq standards, except the CEO (Robert Isom). O’Leary is independent.
- Attendance and engagement: Board met 9 times in 2024 (4 executive sessions of independent directors). Each incumbent director attended at least 75% of aggregate Board and committee meetings; all directors attended the 2024 annual meeting.
- Stockholder engagement: In 2024–2025, AAL engaged with over 55% of its top 30 holders, ~40% of shares outstanding; feedback was shared with CGPR and Compensation Committees.
- Governance practices: Independent chairman (Greg Smith), separate Chair/CEO roles, majority voting, proxy access, special meeting rights, stock ownership guidelines, and prohibition on hedging/pledging.
Fixed Compensation
| Year | Fees Earned or Paid in Cash ($) | Stock Awards ($) | All Other Compensation ($) | Total ($) |
|---|---|---|---|---|
| 2024 | 150,000 | 150,000 (12,908 RSUs; grant 6/5/2024; vests 6/5/2025) | 16,888 (flight privileges $6,461; insurance premium $3,966; remainder not itemized) | 316,888 |
- Director compensation program elements (2024): $100,000 annual Board retainer; $15,000 per committee membership; $20,000 per non-Audit chair ($25,000 for Audit); annual director RSU grant of $150,000 (time-based; vest at next annual meeting or first anniversary). Independent Chairman receives an additional $200,000 RSU grant.
- Travel benefits: Complimentary personal air travel and club status; directors receive tax reimbursements (gross-ups) on imputed income for flight privileges; lifetime travel benefits for service ≥ seven years (gross-ups not provided post-retirement). O’Leary’s itemized 2024 “All Other” shows flight privileges and insurance premium amounts.
Performance Compensation
As Compensation Committee Chair, O’Leary oversaw performance-linked executive pay structures in 2024 (STIP and LTIP). Key metrics and outcomes are provided for oversight context:
| 2024 STIP Metrics | Weight | Threshold | Target | Max | 2024 Result |
|---|---|---|---|---|---|
| Safety education gate | Gate | 91% unlocks plan | — | — | 99.1% (unlocked) |
| Adjusted pre-tax income gate | Gate | $1.5B unlocks financial portion | — | — | $2.2B (unlocked) |
| Relative TRASM vs. Big 3 peers | 14% | 100.50% | 102.50% | 104.50% | 102.23% |
| CASM (ex specials, fuel, profit sharing) | 14% | 13.49 | 13.29 | 13.09 | 13.42 |
| Mainline workforce efficiency | 14% | 2.72 | 2.82 | 2.92 | 2.80 |
| Mainline aircraft utilization | 14% | 10.03 | 10.16 | 10.29 | 10.07 |
| Procurement savings ($M) | 7% | 70 | 80 | 100 | 174 |
| Working capital ($M) | 7% | 175 | 200 | 225 | 344 |
| Mainline CCF | 12% | 99.50% | 99.70% | 99.90% | 99.86% |
| Regional CCF | 5% | 99.50% | 99.70% | 99.90% | 99.95% |
| Mainline D-0 | 6% | 61.30% | 63.30% | 65.30% | 58.89% |
| Regional D-0 | 2% | 71.00% | 73.50% | 76.00% | 72.40% |
| Team member engagement | 5% | 91.00% | 94.00% | 98.00% | 99.40% |
- 2024 STIP payout outcome: 115.42% of target for eligible NEOs, based on weighted attainment (audited by a third-party internal audit consulting firm).
- 2024 LTIP performance metrics (3-year period 2024–2026): Relative EBITDAR margin gap improvement vs. Delta/United (90% weighting; threshold 33 bps, target 67 bps, max 100 bps), and average Net Promoter Score (10%; threshold 34, target 36, max 38).
- 2025 program change (responding to investor feedback): Time-vesting RSUs moved to 3-year ratable vesting (33.33% per year).
Other Directorships & Interlocks
| Company | Board Status | Notes |
|---|---|---|
| Current public company boards | None disclosed | O’Leary’s biography lists past public boards only |
| Past boards and potential interlocks | Medtronic, Calpine, US Airways, Chiron, America West, Del Monte, Alza | No current supplier/customer/competitor interlocks disclosed |
- Independence review: Board annually reviews transactions/relationships; concluded independence for all non-management directors, including O’Leary. No related-party transactions requiring disclosure since Jan 1, 2024.
Expertise & Qualifications
- Investment and financial leadership over four decades, including venture capital experience.
- Extensive public company board tenure across multiple industries (airlines, energy, medical devices, consumer, pharma).
- Compensation Committee leadership for AAL, overseeing executive pay, succession planning, consultant engagement (Korn Ferry; independence affirmed).
Equity Ownership
| Holder | Shares Held Directly | RSUs Vesting ≤60 Days | Total Beneficial Ownership | % of Class | As-of |
|---|---|---|---|---|---|
| Denise O’Leary | 127,872 | 12,908 | 140,780 | <1% | Record date Apr 14, 2025; shares outstanding 659,512,341 |
- Director stock ownership guidelines: Lesser of 5× cash retainer or 15,000 shares; five years to comply; all directors with applicable compliance dates exceed minimum (O’Leary’s 140,780 shares exceed minimum).
- Hedging/pledging: Prohibited for directors and executives.
Governance Assessment
- Committee leadership and refresh: O’Leary’s role as Compensation Chair indicates strong governance involvement; planned rotation to CGPR post–2025 meeting supports board refreshment and diversified oversight.
- Pay-for-performance oversight: Robust linkage of executive pay to profitability, efficiency, operational reliability, and customer metrics; multi-year LTIP with relative EBITDAR and NPS and strengthened 2025 vesting design after investor feedback.
- Stockholder feedback and say-on-pay: 2024 say-on-pay approval was ~76% of shares represented (82% of votes cast excluding abstentions), below decade average (>94%); company attributes this to non-recurring 2023 items not repeated in 2024. As Compensation Chair, O’Leary’s committee engaged with holders and adjusted program elements.
- Independence and conflicts: Board affirmatively determined O’Leary’s independence; no related-party transactions reported; strict prohibitions on hedging/pledging reduce alignment risks.
- Director benefits and optics: Director flight privileges include tax gross-ups on imputed income while serving, which some investors may view unfavorably; O’Leary’s 2024 “All Other” compensation includes flight privileges and legacy life-insurance contribution program premiums. Bold RED FLAG for optics on director gross-ups even if typical in airline industry.
RED FLAGS
- Lower 2024 say-on-pay support (76%) versus historical norms, highlighting investor scrutiny of compensation decisions; requires vigilant engagement and program discipline.
- Director travel benefit tax gross-ups may be viewed as shareholder-unfriendly by some governance frameworks, despite industry custom.
Positive signals
- Clear board refresh and committee rotation plan; independent chairman; robust ownership guidelines; enhanced 2025 vesting design; strong performance metric rigor in STIP/LTIP.
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks